PharmaCyte Biotech annual net profit margin
2011
2012
2013
PharmaCyte Biotech Net Profit Margin Growth & History (PMCB)
PharmaCyte Biotech's net profit margin was −13,142.29% for fiscal 2013.
View full PharmaCyte Biotech company overviewPharmaCyte Biotech annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2013 | 2013-04-30 | −13,142.29% | −10288.67 pp |
| 2012 | 2012-04-30 | −2,853.62% | −1744.29 pp |
| 2011 | 2011-04-30 | −1,109.32% | — |
PharmaCyte Biotech quarterly net profit margin
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2013 | 2012-10-31 | −6,089.01% | −3886.07 pp |
| Q1 2013 | 2012-07-31 | −7,704.75% | −4233.34 pp |
| Q4 2012 | 2012-04-30 | −7,549.18% | −5411.12 pp |
| Q3 2012 | 2012-01-31 | −1,340.73% | −953.18 pp |
| Q2 2012 | 2011-10-31 | −2,202.94% | −1914.20 pp |
| Q1 2012 | 2011-07-31 | −3,471.41% | −2973.41 pp |
| Q4 2011 | 2011-04-30 | −2,138.07% | — |
| Q3 2011 | 2011-01-31 | −387.55% | — |
| Q2 2011 | 2010-10-31 | −288.74% | — |
| Q1 2011 | 2010-07-31 | −498.00% | — |
PharmaCyte Biotech net profit margin trends
Between the periods ended 2011-04-30 and 2013-04-30, PharmaCyte Biotech's net profit margin decreased from −1,109.32% to −13,142.29%, a change of −12032.96 percentage points. The latest reported quarter, Q2 2013, shows −6,089.01%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PharmaCyte Biotech source filings ↗